Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Neonatal Urine Metabolic Profiling and Development of Childhood Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson's Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease

    Research output: Contribution to journalEditorialResearchpeer-review

View graph of relations

Several small molecule biomarkers have been reported in the literature for prediction and diagnosis of (pre)diabetes, its co-morbidities, and complications. Here, we report the development and validation of a novel, quantitative method for the determination of a selected panel of 34 metabolite biomarkers from human plasma. We selected a panel of metabolites indicative of various clinically-relevant pathogenic stages of diabetes. We combined these candidate biomarkers into a single ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method and optimized it, prioritizing simplicity of sample preparation and time needed for analysis, enabling high-throughput analysis in clinical laboratory settings. We validated the method in terms of limits of detection (LOD) and quantitation (LOQ), linearity (R2), and intra- and inter-day repeatability of each metabolite. The method's performance was demonstrated in the analysis of selected samples from a diabetes cohort study. Metabolite levels were associated with clinical measurements and kidney complications in type 1 diabetes (T1D) patients. Specifically, both amino acids and amino acid-related analytes, as well as specific bile acids, were associated with macro-albuminuria. Additionally, specific bile acids were associated with glycemic control, anti-hypertensive medication, statin medication, and clinical lipid measurements. The developed analytical method is suitable for robust determination of selected plasma metabolites in the diabetes clinic.

Original languageEnglish
Article number184
Issue number9
Publication statusPublished - 14 Sep 2019

    Research areas

  • Clinical diagnostics, Diabetes, Mass spectrometry, Metabolomics

ID: 58000878